Division 1 The fee for the assessment of the procedure referred to in Article 6(1) shall be EUR 190 740 where one or two active substances and/or combinations of active substances are included in the assessment. That fee shall be increased by EUR 41 350 per each additional active substance or combination of active substances as of the third active substance or combination of substances. That fee shall not exceed EUR 314 790 irrespective of the number of active substances and/or combinations of active substances.F1
United Kingdom Repealed
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations
Textual amendments
- F1
Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(dd) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)